ADEPT
Test /
CSAM
UPDATED
ACTUAL
Questions
and
CORRECT
Answers
,A 50 year old male presents to a Evaluate for depression at admission to detoxification, as well as
primary care clinic with his wife at the time of discharge, regardless of days of sobriety days
after a completion of three day
inpatient admission for treatment Evidence has been limited on the use of antidepressant
of alcohol withdrawal disorder. medications in patients with co-occuring depression and alcohol
He states that he felt very use disorder (AUD). However, meta-analysis study has shown that
depressed prior to his admission antidepressants outperformed placebo in the treatment of
and he still has some depression depression in patients with AUD (Iovineo). Another study also
and insomnia symptoms, but that showed that among patients with depression and AUD, those
he is feeling better now. Which who were not given antidepressant medication at the time of
of the following is true discharge, 100% resumed alcohol use in 4 months (Greenfield).
regarding the treatment of Another study showed that medication treatment for depression
patients with co-occurring with AUD has significant benefit (Nuens) * Iovineo,
depression and alcohol use Antidepressants for major depressive disorder and dysthymic
disorder? disorder in patients with comorbid AUD:
Wait for 30 days of abstinence
from alcohol before evaluating
for treatment of depression
Treatment of depression with
concurrent alcohol use disorder
have no benefit
Patient is feeling better, so no
need for evaluation of
depression
Depression was part of alcohol
withdrawal symptoms, need to
continue to treatwithdrawal
symptoms
Evaluate for depression at
admission to detoxification, as
well as at the time of
discharge,regardless of days of
sobriety days
,A first time user of oxycodone Ventral tegmental area projections to nucleus accumbens
reports a sudden rush of
euphoria and energy. Which of The positive reinforcing effects of substances and pleasurable
the following neurological behaviors due to dopaminergic projections from the ventral
pathways is primarily tegmental area (VTA) to the nucleus accumbens (NAcc)
responsible for this effect? represents the neural mechanism most consistently implicated in
the development of addiction, especially in early stages. The
Dorsal raphe nucleus NAcc along with the olfactory tubule are located in the ventral
projections to nucleus striatum. The dorsal raphe nucleus is a midbrain cluster of
accumbens serotonergic neurons, which may be relevant for the effects of
certain substances such as hallucinogens and MDMA, but is not
Nucleus accumbens projections as universally implicated in substance and behavioral positive
to ventral tegmental area reinforcement.
Ventral tegmental area
projections to dorsal raphe
nucleus
Ventral tegmental area
projections to nucleus
accumbens
1. As part of a research study, contingency management
volunteers with severe opioid
use disorder receive monetary
vouchers for providing opioid-
negative urine samples. Which
of the following best describes
this behavioral treatment
strategy?
twelve-step facilitation
contingency management
cognitive behavioral therapy
community reinforcement
motivational enhancement
2. A 28-year-old male is brought IV lorazepam
to the ED by his roommate for
agitation after a prolonged
cocaine binge. His BP is 160/90
and HR is 125. The most
appropriate medication would
be:
IV haloperidol
IV lorazepam
IV labetalol
IV chlorpromazine
sublingual clonidine
, 3. You are treating a 17-year-old vitamin E acetate in THC containing vape devices
for acne and depression. During
one of the visits, the patient
mentions that he occasionally
"dabs" with his friends using a
vape device. His mother asks
you about a recent news article
that she read regarding vaping
related lung injury. Which of the
following is thought to be one
of the causative agents in
electronic vaping use associated
lung injury (EVALI)?
vitamin D acetate in THC
containing vape devices
fentanyl adulteration in nicotine
liquid for vape devices
vitamin E acetate in THC
containing vape devices
cannabis resin
caffeine adulteration in nicotine
liquid for vape devices
4. A patient presents to you in provide naloxone kit
the emergency room with an
overdose from IV
heroin/fentanyl. She is treated
with naloxone and now
demanding to leave. You see
that she has been to the ER 5x in
the last 6 months with a similar
presentation. After discussing
the efficacy of buprenorphine
and methadone, she remains
uninterested. Your next strategy
to minimize risk for overdose
and death is:
referral to needle exchange
program
referral to methadone OTP
next day appointment in
addiction clinic
provide naloxone kit
rive first dose of buprenorphine
prior to discharging from the ER
Test /
CSAM
UPDATED
ACTUAL
Questions
and
CORRECT
Answers
,A 50 year old male presents to a Evaluate for depression at admission to detoxification, as well as
primary care clinic with his wife at the time of discharge, regardless of days of sobriety days
after a completion of three day
inpatient admission for treatment Evidence has been limited on the use of antidepressant
of alcohol withdrawal disorder. medications in patients with co-occuring depression and alcohol
He states that he felt very use disorder (AUD). However, meta-analysis study has shown that
depressed prior to his admission antidepressants outperformed placebo in the treatment of
and he still has some depression depression in patients with AUD (Iovineo). Another study also
and insomnia symptoms, but that showed that among patients with depression and AUD, those
he is feeling better now. Which who were not given antidepressant medication at the time of
of the following is true discharge, 100% resumed alcohol use in 4 months (Greenfield).
regarding the treatment of Another study showed that medication treatment for depression
patients with co-occurring with AUD has significant benefit (Nuens) * Iovineo,
depression and alcohol use Antidepressants for major depressive disorder and dysthymic
disorder? disorder in patients with comorbid AUD:
Wait for 30 days of abstinence
from alcohol before evaluating
for treatment of depression
Treatment of depression with
concurrent alcohol use disorder
have no benefit
Patient is feeling better, so no
need for evaluation of
depression
Depression was part of alcohol
withdrawal symptoms, need to
continue to treatwithdrawal
symptoms
Evaluate for depression at
admission to detoxification, as
well as at the time of
discharge,regardless of days of
sobriety days
,A first time user of oxycodone Ventral tegmental area projections to nucleus accumbens
reports a sudden rush of
euphoria and energy. Which of The positive reinforcing effects of substances and pleasurable
the following neurological behaviors due to dopaminergic projections from the ventral
pathways is primarily tegmental area (VTA) to the nucleus accumbens (NAcc)
responsible for this effect? represents the neural mechanism most consistently implicated in
the development of addiction, especially in early stages. The
Dorsal raphe nucleus NAcc along with the olfactory tubule are located in the ventral
projections to nucleus striatum. The dorsal raphe nucleus is a midbrain cluster of
accumbens serotonergic neurons, which may be relevant for the effects of
certain substances such as hallucinogens and MDMA, but is not
Nucleus accumbens projections as universally implicated in substance and behavioral positive
to ventral tegmental area reinforcement.
Ventral tegmental area
projections to dorsal raphe
nucleus
Ventral tegmental area
projections to nucleus
accumbens
1. As part of a research study, contingency management
volunteers with severe opioid
use disorder receive monetary
vouchers for providing opioid-
negative urine samples. Which
of the following best describes
this behavioral treatment
strategy?
twelve-step facilitation
contingency management
cognitive behavioral therapy
community reinforcement
motivational enhancement
2. A 28-year-old male is brought IV lorazepam
to the ED by his roommate for
agitation after a prolonged
cocaine binge. His BP is 160/90
and HR is 125. The most
appropriate medication would
be:
IV haloperidol
IV lorazepam
IV labetalol
IV chlorpromazine
sublingual clonidine
, 3. You are treating a 17-year-old vitamin E acetate in THC containing vape devices
for acne and depression. During
one of the visits, the patient
mentions that he occasionally
"dabs" with his friends using a
vape device. His mother asks
you about a recent news article
that she read regarding vaping
related lung injury. Which of the
following is thought to be one
of the causative agents in
electronic vaping use associated
lung injury (EVALI)?
vitamin D acetate in THC
containing vape devices
fentanyl adulteration in nicotine
liquid for vape devices
vitamin E acetate in THC
containing vape devices
cannabis resin
caffeine adulteration in nicotine
liquid for vape devices
4. A patient presents to you in provide naloxone kit
the emergency room with an
overdose from IV
heroin/fentanyl. She is treated
with naloxone and now
demanding to leave. You see
that she has been to the ER 5x in
the last 6 months with a similar
presentation. After discussing
the efficacy of buprenorphine
and methadone, she remains
uninterested. Your next strategy
to minimize risk for overdose
and death is:
referral to needle exchange
program
referral to methadone OTP
next day appointment in
addiction clinic
provide naloxone kit
rive first dose of buprenorphine
prior to discharging from the ER
